Table 2 Clinicopathological predictors of overall survival

From: Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer

  

Overall survival

  

Univariate analysis

Multivariate analysis

Variable

N =220

Hazard ratio (95% CI)

P -value

Hazard ratio (95% CI)

P -value

pTNM stage

I/II/III

126/65/29

1.4 (1.2–1.6)

<0.001*

1.4 (1.2–1.7)

<0.001*

Grade

Good/Moderate/Poor

43/110/67

1.6 (1.1–2.3)

0.02*

  

Lymphovascular invasion

Absent/Present

120/100

2.5 (1.4–4.3)

0.001*

  

Pleural invasion

Absent/Present

176/44

2.3 (1.3–4.1)

0.003*

2.2 (1.2–3.9)

0.02*

Resection margin

Clear/involved

189/31

0.8 (0.4–1.7)

0.64

  

NLR

<5/>5

198/21

2.3 (1.0–5.0)

0.04*

3.8 (1.6 –8.9)

0.002*

PLR

<300/>300

211/8

1.6 (0.6–5.6)

0.32

  

mGPS

0/1/2

131/39/29

1.5 (1.0–2.0)

0.02*

  
  1. Abbreviations: CI=confidence interval; mGPS=modified Glasgow Prognostic Score; NLR=neutrophil-to-lymphocyte ratio; PLR=platelet-to-lymphocyte ratio; pTNM=Pathological Tumour Node Metastasis stage according to the 7th Edition of the TNM Classification.
  2. Associations reaching statistical significance (P<0.05) are marked with an asterisk (*).
Back to article page